Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cellular Injury IV: Necrosis01:16

Cellular Injury IV: Necrosis

Necrosis is a form of irreversible cell death caused by severe injury such as ischemia, toxins, or trauma. Unlike programmed cell death, it is an uncontrolled, pathological process that typically provokes inflammation in surrounding tissues.Pathophysiologic ChangesNecrosis begins when cells sustain critical damage, leading to swelling of organelles, particularly mitochondria, and rapid ATP depletion. As energy levels decline, membrane ion pumps fail, leading to calcium influx and eventually,...
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Pneumothorax II: Pathophysiology01:08

Pneumothorax II: Pathophysiology

Pneumothorax means the presence of air in the pleural space — the thin potential gap between the visceral and parietal pleura. This condition disrupts the normal pressure balance that keeps the lungs inflated, leading to partial or complete collapse of the affected lung.Normal physiologyUnder normal conditions, the pleural space maintains a slightly negative intrapleural pressure, which keeps the lungs expanded against the chest wall. This negative pressure creates a delicate balance between...
Hypoxia01:23

Hypoxia

Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cross-reactive anti-prophage antibodies and bacterial heteroresistance implicated in phage therapeutic failure.

Nature medicine·2026
Same author

Radiometer calibration using machine learning.

Scientific reports·2025
Same author

Bovine milk and milk protein- promotor or inhibitor of bacterial biofilm formation at the tooth surface?

BMC oral health·2025
Same author

The occurrence of low thyroxine concentrations and response to thyrotropin-releasing hormone using equine and canine assays in a population of Standardbred racehorses in Prince Edward Island, Canada.

Journal of equine veterinary science·2025
Same author

Interactive effects of nitrogen deposition and climate change on a globally rare forest geophyte.

Plant biology (Stuttgart, Germany)·2024
Same author

RENEB Inter-Laboratory Comparison 2021: Inter-Assay Comparison of Eight Dosimetry Assays.

Radiation research·2023

Related Experiment Videos

[Hyperbaric oxygenation for necrotizing soft tissue infections: pro].

M Schmale1, A Fichtner, C Pohl

  • 1Klinik für Anästhesiologie und operative Intensivmedizin, Universitätsklinikum Halle (Saale), Halle (Saale), Deutschland. michael.bucher@uk-halle.de

Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen
|October 31, 2012
PubMed
Summary

Hyperbaric oxygen therapy (HBOT) enhances multidisciplinary treatment for necrotizing soft tissue infections, improving outcomes. Excluding HBOT when available denies patients an effective therapeutic option.

Related Experiment Videos

Area of Science:

  • Infectious Diseases
  • Wound Healing
  • Hyperbaric Medicine

Context:

  • Necrotizing soft tissue infections (NSTIs) present a complex spectrum of symptoms with high mortality risk.
  • Treatment effectiveness is influenced by infection dissemination and causative bacteria.
  • Multidisciplinary care, including surgical debridement, critical care, and antibiotics, is standard for NSTIs.

Purpose:

  • To evaluate the role of Hyperbaric Oxygen Therapy (HBOT) as an adjunct treatment for NSTIs.
  • To highlight HBOT's benefits in improving outcomes within a comprehensive treatment strategy.

Summary:

  • HBOT demonstrates bactericidal and bacteriostatic effects, crucial for combating bacterial infections in NSTIs.
  • It enhances cellular oxygen supply, optimizing metabolic processes essential for wound healing.
  • Integrating HBOT into existing multidisciplinary care significantly boosts treatment efficacy.

Impact:

  • HBOT inclusion increases the effectiveness of surgical, critical care, and antibiotic interventions for NSTIs.
  • Availability of HBOT facilities presents an opportunity to optimize patient care and reduce mortality.
  • Omitting HBOT when available represents a failure to utilize a proven, effective therapeutic modality.